ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | 0.0% | 469 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $5,000 | +25.0% | 469 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -42.9% | 469 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -41.7% | 469 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $12,000 | +20.0% | 469 | +17.2% | 0.01% | +25.0% |
| Q2 2021 | $10,000 | -28.6% | 400 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $14,000 | +40.0% | 400 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $10,000 | -33.3% | 400 | 0.0% | 0.01% | -44.4% |
| Q3 2020 | $15,000 | -11.8% | 400 | 0.0% | 0.01% | -18.2% |
| Q2 2020 | $17,000 | +112.5% | 400 | 0.0% | 0.01% | +83.3% |
| Q1 2020 | $8,000 | -20.0% | 400 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $10,000 | -9.1% | 400 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $11,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $11,000 | -8.3% | 400 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $12,000 | +9.1% | 400 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $11,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |